These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 150548)
1. [Cholinergizing treatment in hyperkinesis]. Domzał T Neurol Neurochir Pol; 1978; 12(3):257-61. PubMed ID: 150548 [TBL] [Abstract][Full Text] [Related]
2. Drug treatment of diseases characterized by abnormal movements. Marsden CD Proc R Soc Med; 1973 Sep; 66(9):871-3. PubMed ID: 4281483 [No Abstract] [Full Text] [Related]
3. [Movement abnormalities and their treatment in general practice]. Gonce M; Delwaide PJ Rev Med Liege; 1979 Oct; 34(19):797-802. PubMed ID: 297251 [No Abstract] [Full Text] [Related]
4. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. Chen JJ; Ondo WG; Dashtipour K; Swope DM Clin Ther; 2012 Jul; 34(7):1487-504. PubMed ID: 22749259 [TBL] [Abstract][Full Text] [Related]
5. [Use of haloperidol in the treatment of extrapyramidal compulsive movement]. Kivalo E; Weckman N Nervenarzt; 1970 Nov; 41(11):567-9. PubMed ID: 4249744 [No Abstract] [Full Text] [Related]
6. [Therapeutical approach to involuntary movements (author's transl)]. Allain H; Sabouraud O Sem Hop; 1979 Feb 8-15; 55(5-6):262-4. PubMed ID: 219537 [TBL] [Abstract][Full Text] [Related]
7. Tetrabenazine in the treatment of hyperkinetic movement disorders. Jankovic J Adv Neurol; 1983; 37():277-89. PubMed ID: 6574695 [No Abstract] [Full Text] [Related]
8. A review of clinical trials of lithium in neurology. Yung CY Pharmacol Biochem Behav; 1984; 21 Suppl 1():57-64. PubMed ID: 6240662 [TBL] [Abstract][Full Text] [Related]
9. Tetrabenazine in the treatment of hyperkinetic movement disorders. Kenney C; Jankovic J Expert Rev Neurother; 2006 Jan; 6(1):7-17. PubMed ID: 16466307 [TBL] [Abstract][Full Text] [Related]
10. Drug treatment of hyperkinetic movement disorders. Fahn S Semin Neurol; 1987 Jun; 7(2):192-208. PubMed ID: 3332454 [No Abstract] [Full Text] [Related]
11. Chapter 33: the history of movement disorders. Lanska DJ Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136 [TBL] [Abstract][Full Text] [Related]
12. The trial use of clozapine for abnormal involuntary movement disorders. Caine ED; Polinsky RJ; Kartzinel R; Ebert MH Am J Psychiatry; 1979 Mar; 136(3):317-20. PubMed ID: 154301 [TBL] [Abstract][Full Text] [Related]
14. Predictive factors for tolerability of tetrabenazine in patients with hyperkinetic movement disorders. Sahin T; Yilmaz R; Akbostanci MC Parkinsonism Relat Disord; 2020 May; 74():36-37. PubMed ID: 32311641 [No Abstract] [Full Text] [Related]
15. Deutetrabenazine: Treatment of hyperkinetic aspects of Huntington's disease, tardive dyskinesia and Tourette syndrome. Paton DM Drugs Today (Barc); 2017 Feb; 53(2):89-102. PubMed ID: 28387387 [TBL] [Abstract][Full Text] [Related]
16. Deanol in Gilles de la Tourette Syndrome: a preliminary investigation. Pinta ER Dis Nerv Syst; 1977 Mar; 38(3):214-5. PubMed ID: 264808 [TBL] [Abstract][Full Text] [Related]
17. [Pathogenesis and treatment of tic-type hyperkinesis in children]. Bondarenko ES; Malyshev IuI; Blagosklonov AV; Lebedev VN Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(10):1449-56. PubMed ID: 6947655 [TBL] [Abstract][Full Text] [Related]
18. Clozapine therapy for Parkinson's disease and other movement disorders. Pfeiffer C; Wagner ML Am J Hosp Pharm; 1994 Dec; 51(24):3047-53. PubMed ID: 7856623 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis. Davis KL; Berger PA Biol Psychiatry; 1978 Feb; 13(1):23-49. PubMed ID: 146524 [TBL] [Abstract][Full Text] [Related]